1. Home
  2. ZLAB vs RNW Comparison

ZLAB vs RNW Comparison

Compare ZLAB & RNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • RNW
  • Stock Information
  • Founded
  • ZLAB 2013
  • RNW 2011
  • Country
  • ZLAB China
  • RNW United Kingdom
  • Employees
  • ZLAB N/A
  • RNW N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • RNW Electric Utilities: Central
  • Sector
  • ZLAB Health Care
  • RNW Utilities
  • Exchange
  • ZLAB Nasdaq
  • RNW Nasdaq
  • Market Cap
  • ZLAB 3.4B
  • RNW 2.7B
  • IPO Year
  • ZLAB 2017
  • RNW N/A
  • Fundamental
  • Price
  • ZLAB $32.58
  • RNW $7.73
  • Analyst Decision
  • ZLAB Buy
  • RNW Strong Buy
  • Analyst Count
  • ZLAB 6
  • RNW 1
  • Target Price
  • ZLAB $57.22
  • RNW $7.50
  • AVG Volume (30 Days)
  • ZLAB 819.9K
  • RNW 720.4K
  • Earning Date
  • ZLAB 11-11-2025
  • RNW 08-13-2025
  • Dividend Yield
  • ZLAB N/A
  • RNW N/A
  • EPS Growth
  • ZLAB N/A
  • RNW 1063.89
  • EPS
  • ZLAB N/A
  • RNW 0.28
  • Revenue
  • ZLAB $427,799,000.00
  • RNW $1,320,468,726.00
  • Revenue This Year
  • ZLAB $42.62
  • RNW N/A
  • Revenue Next Year
  • ZLAB $55.12
  • RNW $16.12
  • P/E Ratio
  • ZLAB N/A
  • RNW $27.51
  • Revenue Growth
  • ZLAB 32.56
  • RNW 37.94
  • 52 Week Low
  • ZLAB $20.17
  • RNW $5.15
  • 52 Week High
  • ZLAB $44.34
  • RNW $7.89
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 48.51
  • RNW 55.12
  • Support Level
  • ZLAB $31.68
  • RNW $7.57
  • Resistance Level
  • ZLAB $33.06
  • RNW $7.84
  • Average True Range (ATR)
  • ZLAB 1.34
  • RNW 0.15
  • MACD
  • ZLAB 0.21
  • RNW -0.01
  • Stochastic Oscillator
  • ZLAB 80.97
  • RNW 77.78

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About RNW ReNew Energy Global plc

ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.

Share on Social Networks: